Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Cui Tiankai. Photo: Xinhua/Liu Jie via Getty Images

The State Department is commending China's ambassador to the U.S., Cui Tiankai, for distancing himself from a coronavirus conspiracy theory that the spokesman for China's Foreign Ministry has been pushing.

Driving the news: "We welcome Ambassador Cui's comments calling the Chinese Foreign Ministry's statement a 'crazy thing' that blamed the U.S. Army for the #coronavirus outbreak in Wuhan," the State Department's spokesperson Morgan Ortagus tweeted on Tuesday.

  • "Saving lives is more important than saving face."

Why this matters: China's pushing of this conspiracy theory has inflamed what is already an extremely fraught relationship between the superpowers amid a global pandemic. Ortagus' tweet, coupled with Cui's more conciliatory statements in an interview with "Axios on HBO," may signal the end of the fight over this conspiracy theory.

The backstory: In a rare interview, Cui told "Axios on HBO" that he stands by his belief that it's "crazy" to spread rumors about the coronavirus originating from a military laboratory in the United States.

  • Cui called this exact conspiracy theory "crazy" more than a month ago on CBS' "Face the Nation." But that was before the spokesperson for the Chinese Ministry of Foreign Affairs, Zhao Lijian, began publicly promoting the conspiracy.
  • The fact that Cui distanced himself from his colleague's statements sends an important signal from the top Chinese government official in the U.S.
  • Top Trump officials, including the president, have expressed their outrage at Chinese officials for trying to spread the theory that the U.S. military brought the coronavirus to China. The State Department even called in Cui to take him to task.

Reality check: There's not a credible epidemiologist in the world who has shown evidence that the virus originated anywhere but China. Scientists believe the virus emerged from animals sold in a market in Wuhan, where the first cases of the disease were discovered.

Go deeper: More highlights from the Chinese ambassador's "Axios on HBO" interview

Go deeper

Virginia lawmakers vote to legalize marijuana in 2024

Virginia Gov. Ralph Northam. Photo: Alex Edelman/Getty Images

Lawmakers in Virginia on Saturday approved compromise legislation that would legalize marijuana in 2024, putting the state a step closer to becoming the first in the South to end prohibition on the drug, the Richmond Times-Dispatch reports.

Why it matters: The legislation will make Virginia the 16th state to legalize marijuana, per Politico. It would add to a slate of laws that have seen Virginia move in a more progressive direction during the tenure of Gov. Ralph Northam.

Scammers seize on COVID confusion

Data: FTC; Chart: Sara Wise/Axios

Scamming has skyrocketed in the past year, and much of the increase is attributed to COVID-related scams, more recently around vaccines.

Why it matters: The pandemic has created a prime opportunity for scammers to target people who are already confused about the chaotic rollouts of things like stimulus payments, loans, contact tracing and vaccines. Data shows that older people who aren't digitally literate are the most vulnerable.

14 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.